Abstract
Critique on "Real-World Effectiveness of First-Line Lenvatinib Therapy in Advanced Hepatocellular Carcinoma: Current Insights" [Response to Letter
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have